Kaufmaga, From what I remember from past releases, Hepatic Infusion has been accepted in Germany as the main treatment for cancer metastasized in the Liver. As more countries recognize its results, I don't see why it wouldn't be in high demand world wide for that matter. This Optimistic view cost me a lot here, I want to see more progression than just this last agreement. Why aren't case results from Europe publicized? I look forward to their next quarterly report.
They are not getting a large flat rate per year. The only thing that is clear is risk of bankruptcy should be considered much lower. Most warrants are still on the table to my knowledge so very large dilution is quite possible. I bought small, I will not buy big unless there is a clear path to a significant target price
News 
Market Data 
Discover 
